Extracorporeal liver support therapy with prometheus in patients with liver failure in the intensive care unit

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 5, 2009, Pages 426-430

  Oppert, Michael ^a   Rademacher, Sibylle ^a   Petrasch, Kathrin ^a   Jörres, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Extracorporeal liver support; Liver failure; Prometheus

Indexed keywords

BILIRUBIN; INOTROPIC AGENT;

ADULT; AGED; ALBUMIN DIALYSIS; APACHE; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEVICE; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; FORWARD HEART FAILURE; HEMODYNAMICS; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LIVER FAILURE; MALE; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BILIRUBIN; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODYNAMICS; HUMANS; INTENSIVE CARE; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 70349785419     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00761.x     Document Type: Article

References (24)

1. O'Grady JG. Acute liver failure. Postgrad Med J 2005 81 : 148 154.
2. Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007 9 : 66 73.
3. Bauer M, Winning J, Kortgen A. Liver failure. Curr Opin Anaesthesiol 2005 18 : 111 116.
4. Evenepoel P, Laleman W, Wilmer A et al. Detoxifying capacity and kinetics of Prometheus - a new extracorporeal system for the treatment of liver failure. Blood Purif 2005 23 : 349 358.
5. Stange J, Mitzner SR, Risler T et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999 23 : 319 330.
6. Krisper P, Haditsch B, Stauber R et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005 43 : 451 457.
7. Falkenhagen D, Strobl W, Vogt G et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999 23 : 81 6.
8. Vienken J, Christmann H. How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial 2006 10 : 125 131.
9. Evenepoel P, Laleman W, Wilmer A et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006 30 : 276 284.
10. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006 10 : R108.
11. Sorkine P, Ben AR, Szold O et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001 29 : 1332 1336. (Pubitemid 32641793)
12. Hassanein TI, Tofteng F, Brown RS Jr. et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007 46 : 1853 1862.
13. Heemann U, Treichel U, Loock J et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002 36 : 949 958.
14. Stadlbauer V, Krisper P, Aigner R et al. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006 10 : R169.
15. Schmidt LE, Sorensen VR, Svendsen LB, Hansen BA, Larsen FS. Hemodynamic changes during a single treatment with the molecular adsorbent recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001 7 : 1034 1039.
16. Rifai K, Manns MP. Review article: clinical experience with Prometheus. Ther Apher Dial 2006 10 : 132 137.
17. Rifai K. Extracorporeal albumin dialysis. Hepatol Res 2008 38 : S41 5 (s1The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan).
18. Stadlbauer V, Davies NA, Sen S, Jalan R. Artificial liver support systems in the management of complications of cirrhosis. Semin Liver Dis 2008 28 : 96 109.
19. Mas A, Rodes J. Fulminant hepatic failure. Lancet 1997 349 : 1081 1085.
20. Mitzner SR, Stange J, Klammt S et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000 6 : 277 286.
21. Rifai K, Hafer C, Rosenau J et al. Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scand J Gastroenterol 2006 41 : 1212 1217.
22. Bellmann R, Feistritzer C, Zoller H et al. Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases. ASAIO J 2004 50 : 387 391.
23. Kjaergard LL, Liu J, Ls-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003 289 : 217 222.
24. Bakos A, Rikker C, Tovarosi S, Karteszi M Therapeutic effect of the latest extracorporeal elimination procedure (Prometheus treatment) in acute liver failure caused by intoxication Orv Hetil 2007 148 : 1981 1988.